✓ Last verified: February 9, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: Led by Dr. Irfan Handoo — one of the first 300 physicians in the United States to offer IV ketamine therapy — Kansas City Psychiatry Partners is the KC metro’s most established interventional psychiatry practice with IV ketamine, Spravato, AND Deep TMS under one roof.
| Review Scores | Led by Kansas City’s IV ketamine pioneer; offers full interventional psychiatry suite (IV ketamine + Spravato + Deep TMS) |
| Location | Overland Park, KS |
| Address | 7381 West 133rd Street, Suite 401, Overland Park, KS 66213 |
| Phone | (913) 346-0000 |
| Website | kcpsychiatrypartners.com |
| Treatments | IV Ketamine Infusion, Spravato (Esketamine) Nasal Spray, Deep TMS Therapy, Psychiatric Medication Management |
| Conditions Treated | Treatment-Resistant Depression, Anxiety, PTSD, OCD, Bipolar Disorder, Suicidal Ideation |
| Cost | Contact for pricing |
| Insurance | Contact for insurance verification |
| Clinical Lead | Dr. Irfan Handoo, MD — Board-certified psychiatrist, founder, and one of the first 300 physicians nationally to offer IV ketamine (since 2016) |
HealingMaps Take: Kansas City Psychiatry Partners’ clinical distinction rests on a specific historical fact: Dr. Irfan Handoo was among the first 300 physicians in the United States to offer IV ketamine treatments, starting in Kansas City in 2016. That early-adopter status translates into roughly a decade of continuous clinical experience with IV ketamine, during which he has refined protocols, observed response patterns across hundreds of patients, and developed clinical intuition about dose adjustments, timing, and treatment sequencing that newer providers simply cannot match. That depth of experience is especially valuable for complex or previously-treatment-resistant patients who have failed multiple interventions. The Overland Park flagship at 7381 W 133rd Street (Suite 401) offers the full interventional psychiatry suite — IV ketamine, Spravato, Deep TMS, and medication management — meaning patients can pivot between modalities based on clinical response without switching practices. Deep TMS (Brainsway’s H-coil technology) penetrates deeper brain regions than standard TMS and is FDA-approved for treatment-resistant depression and OCD, offering an additional tool beyond what most KC clinics provide. For Kansas City metro patients with treatment-resistant conditions who want maximum clinical depth under a single psychiatrist, Kansas City Psychiatry Partners is the premium option.
Market Position: Kansas City Psychiatry Partners (Dr. Irfan Handoo) is a Spravato-certified clinic in the Park metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. Kansas City Psychiatry Partners (Dr. Irfan Handoo) has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Johnson County, KS, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
75% of ketamine patients report zero insurance coverage for their treatment — meaning most patients pay cash and should factor the full cost of care into their treatment decision. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 5-question summary is matched to the protocols and conditions Kansas City Psychiatry Partners (Dr. Irfan Handoo) treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Kansas City Psychiatry Partners (Dr. Irfan Handoo) offers Spravato and IV ketamine — a 2-protocol practice. Patients can switch between or combine modalities without changing providers. Confirm specific dosing schedules and which protocols are recommended for your condition during your consult.
Yes — Kansas City Psychiatry Partners (Dr. Irfan Handoo) offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Kansas City Psychiatry Partners (Dr. Irfan Handoo) treats depression via Spravato (FDA-approved for TRD), and IV ketamine (off-label, evidence-based). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Kansas City Psychiatry Partners (Dr. Irfan Handoo) treats PTSD. Both Spravato and IV ketamine can be used for trauma. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Kansas City Psychiatry Partners (Dr. Irfan Handoo) treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply